ArticleClinical and molecular hepatology2026
Correspondence to editorial on "Gut microbiota-mediated berberine metabolism ameliorates cholestatic liver disease by suppressing 5-hydroxytryptamine production".
Dianji Tu et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.